These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 15177773)

  • 61. Tau protein, phosphorylated tau protein and beta-amyloid42 in the cerebrospinal fluid of multiple sclerosis patients.
    Valis M; Talab R; Stourac P; Andrys C; Masopust J
    Neuro Endocrinol Lett; 2008 Dec; 29(6):971-6. PubMed ID: 19112391
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Soluble Fas receptor and soluble Fas ligand in the serum of women with uterine tumors.
    Kondera-Anasz Z; Mielczarek-Palacz A; Sikora J
    Apoptosis; 2005 Oct; 10(5):1143-9. PubMed ID: 16151647
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Activated terminal complement in cerebrospinal fluid in Guillain-Barré syndrome and multiple sclerosis.
    Sanders ME; Koski CL; Robbins D; Shin ML; Frank MM; Joiner KA
    J Immunol; 1986 Jun; 136(12):4456-9. PubMed ID: 3711661
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Involvement of apoptosis in patients with diabetic nephropathy: A study on plasma soluble Fas levels and pathological findings.
    Baba K; Minatoguchi S; Sano H; Kagawa T; Murata I; Takemura G; Hirano T; Ohashi H; Takemura M; Fujiwara T; Fujiwara H
    Nephrology (Carlton); 2004 Apr; 9(2):94-9. PubMed ID: 15056269
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Impaired hypothalamic-pituitary-adrenal axis activity in patients with multiple sclerosis.
    Ysrraelit MC; Gaitán MI; Lopez AS; Correale J
    Neurology; 2008 Dec; 71(24):1948-54. PubMed ID: 19064876
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cobalamin as a regulator of serum and cerebrospinal fluid levels of normal prions.
    Scalabrino G; Veber D; Briani C; Milani S; Terralavoro A; Brenna S; Valenti L; Silani V; Morelli C; Peracchi M
    J Clin Neurosci; 2013 Jan; 20(1):134-8. PubMed ID: 23146213
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Potential relevance of cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-2 (MMP-2) as markers of disease remission in patients with multiple sclerosis.
    Fainardi E; Castellazzi M; Tamborino C; Trentini A; Manfrinato MC; Baldi E; Tola MR; Dallocchio F; Granieri E; Bellini T
    Mult Scler; 2009 May; 15(5):547-54. PubMed ID: 19318509
    [TBL] [Abstract][Full Text] [Related]  

  • 68. High levels of sFas and PBMC apoptosis before and after excision of malignant melanoma--case report.
    Alecu M; Coman G; Dănăilă L
    Roum Arch Microbiol Immunol; 2002; 61(4):267-73. PubMed ID: 15055260
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Plasma levels of soluble adhesion molecules sPECAM-1, sP-selectin and sE-selectin are associated with relapsing-remitting disease course of multiple sclerosis.
    Kuenz B; Lutterotti A; Khalil M; Ehling R; Gneiss C; Deisenhammer F; Reindl M; Berger T
    J Neuroimmunol; 2005 Oct; 167(1-2):143-9. PubMed ID: 16040131
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Neuroactive steroid levels in plasma and cerebrospinal fluid of male multiple sclerosis patients.
    Caruso D; Melis M; Fenu G; Giatti S; Romano S; Grimoldi M; Crippa D; Marrosu MG; Cavaletti G; Melcangi RC
    J Neurochem; 2014 Aug; 130(4):591-7. PubMed ID: 24766130
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Increased autotaxin activity in multiple sclerosis.
    Zahednasab H; Balood M; Harirchian MH; Mesbah-Namin SA; Rahimian N; Siroos B
    J Neuroimmunol; 2014 Aug; 273(1-2):120-3. PubMed ID: 24984830
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Correlation between DJ-1 levels in the cerebrospinal fluid and the progression of disabilities in multiple sclerosis patients.
    Hirotani M; Maita C; Niino M; Iguchi-Ariga S; Hamada S; Ariga H; Sasaki H
    Mult Scler; 2008 Sep; 14(8):1056-60. PubMed ID: 18632777
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Serum and cerebrospinal fluid C2 in multiple sclerosis.
    Delasnerie-Laupretre N; Prevot D; Martin-Mondiere C; Eizenbaum JF; Degos JD; Sobel AT
    J Clin Lab Immunol; 1981 Jul; 6(1):23-5. PubMed ID: 7265172
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Caspase-1 levels in biological fluids from patients with multiple sclerosis and from patients with other neurological and non-neurological diseases.
    Franciotta D; Martino G; Zardini E; Furlan R; Bergamaschi R; Gironi M; Bergami A; Angelini G; De Benedetti F; Pignatti P; Moscato G; Cosi V
    Eur Cytokine Netw; 2002; 13(1):99-103. PubMed ID: 11956027
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cerebrospinal fluid in multiple sclerosis.
    Lowenthal A; Karcher D
    Clin Neurosci; 1994; 2(3-4):211-4. PubMed ID: 7749890
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Is the modulatory effect of pregnancy in multiple sclerosis associated with changes in blood apoptotic molecules?
    Rinta S; Airas L; Elovaara I
    Acta Neurol Scand; 2010 Sep; 122(3):168-74. PubMed ID: 20695850
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Influx of nonactivated T lymphocytes into the cerebrospinal fluid during relapse of multiple sclerosis.
    Oksaranta O; Tarvonen S; Ilonen J; Poikonen K; Reunanen M; Panelius M; Salonen R
    Ann Neurol; 1995 Sep; 38(3):465-8. PubMed ID: 7668836
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Serum and cerebrospinal fluid copper levels in patients with multiple sclerosis based on emission spectral analysis findings].
    Kravtsova AF
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1967; 67(2):213-6. PubMed ID: 5590869
    [No Abstract]   [Full Text] [Related]  

  • 79. [Immunoelectrophoretic study of serum and cerebrospinal proteins in multiple sclerosis].
    Paltrinieri E
    Acta Neurol (Napoli); 1967; 22(2):216-27. PubMed ID: 5606826
    [No Abstract]   [Full Text] [Related]  

  • 80. Soluble E-selectin in the serum and cerebrospinal fluid of patients with multiple sclerosis and human T-lymphotropic virus type 1-associated myelopathy.
    Tsukada N; Miyagi K; Matsuda M; Yanagisawa N
    Neurology; 1995 Oct; 45(10):1914-8. PubMed ID: 7477992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.